Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors ; volume:10 ; number:1 ; day:23 ; month:4 ; year:2019 ; pages:1-15 ; date:12.2019
Nature Communications ; 10, Heft 1 (23.4.2019), 1-15, 12.2019
- Classification
-
Naturwissenschaften
- Creator
-
Duan, Xiaopin
Chan, Christina
Han, Wenbo
Guo, Nining
Weichselbaum, Ralph R.
Lin, Wenbin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-019-09221-x
- URN
-
urn:nbn:de:101:1-2019051100563435583691
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Duan, Xiaopin
- Chan, Christina
- Han, Wenbo
- Guo, Nining
- Weichselbaum, Ralph R.
- Lin, Wenbin
- SpringerLink (Online service)
Other Objects (12)
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer
A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade
Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer
Dual immune checkpoint blockade in gastroesophageal tumors: never say never
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer
A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade
Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer
Dual immune checkpoint blockade in gastroesophageal tumors: never say never
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer
A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade
Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer
Dual immune checkpoint blockade in gastroesophageal tumors: never say never
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors